News > Aurobindo Pharma gets USFDA nod for cancer treatment injection
Aurobindo Pharma gets USFDA nod for cancer treatment injection
28/08/2021 06:12 PM | Click to read full article
Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in the treatment of several types of cancer.
"The product, Cyclophosphamide Injection 500 mg/2.5 mL and 1 g/5 mL vial shall be launched in the US market in the near term and will be manufactured in Eugia's manufacturing facility in India," Aurobindo Pharma said.